1-20 of 51
proliferative diabetic retinopathy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526

Jennifer Lopez, William S. Gange, Khristina Lung, Benjamin Y. Xu, Seth A. Seabury, Brian C. Toy
Journal: Diabetes Care
Diabetes Care 2022;45(3):e61–e62
https://doi.org/10.2337/dci21-0057
Published: 04 March 2022
View article titled, Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526
Open the PDF for Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526 in another window
Journal Articles

Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526

Vincent Rigalleau, Alice Larroumet, Kamel Mohammedi, Laurence Baillet-Blanco, Marie Monlun, Marie-Noelle Delyfer, Jean-François Korobelnik, Ninon Foussard
Journal: Diabetes Care
Diabetes Care 2022;45(3):e60
https://doi.org/10.2337/dc21-2254
Published: 04 March 2022
View article titled, Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526
Open the PDF for Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526 in another window
Journal Articles

Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes

William S. Gange, Jennifer Lopez, Benjamin Y. Xu, Khristina Lung, Seth A. Seabury, Brian C. Toy
Journal: Diabetes Care
Diabetes Care 2021;44(11):2518–2526
https://doi.org/10.2337/dc21-0228
Published: 02 September 2021
View article titled, Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes
Open the PDF for Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes in another window
Journal Articles

Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study

António C.-V. Martinho, Inês P. Marques, Ana L. Messias, Torcato Santos, Maria H. Madeira, David C. Sousa, Conceição Lobo, José Cunha-Vaz
Journal: Diabetes Care
Diabetes Care 2021;44(1):e12–e14
https://doi.org/10.2337/dc20-1125
Published: 06 November 2020
View article titled, Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study
Open the PDF for Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study in another window
Journal Articles

Development and Validation of an Automated Diabetic Retinopathy Screening Tool for Primary Care Setting

Alauddin Bhuiyan, Arun Govindaiah, Avnish Deobhakta, Meenakashi Gupta, Richard Rosen, Sophia Saleem, R. Theodore Smith
Journal: Diabetes Care
Diabetes Care 2020;43(10):e147–e148
https://doi.org/10.2337/dc19-2133
Published: 11 September 2020
View article titled, Development and Validation of an Automated Diabetic Retinopathy Screening Tool for Primary Care Setting
Open the PDF for Development and Validation of an Automated Diabetic Retinopathy Screening Tool for Primary Care Setting in another window
Journal Articles

Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study

Maria Nordwall, Mats Fredriksson, Johnny Ludvigsson, Hans J. Arnqvist
Journal: Diabetes Care
Diabetes Care 2019;42(4):609–616
https://doi.org/10.2337/dc18-1950
Published: 31 January 2019
View article titled, Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study
Open the PDF for Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study in another window
Includes: Supplementary data
Journal Articles

Ventral Striatum, but Not Cortical Volume Loss, Is Related to Cognitive Dysfunction in Type 1 Diabetic Patients With and Without Microangiopathy

Eelco van Duinkerken, Menno M. Schoonheim, Martijn D. Steenwijk, Martin Klein, Richard G. IJzerman, Annette C. Moll, Martijn W. Heymans, Frank J. Snoek, Frederik Barkhof, Michaela Diamant
Journal: Diabetes Care
Diabetes Care 2014;37(9):2483–2490
https://doi.org/10.2337/dc14-0016
Published: 07 August 2014
View article titled, Ventral Striatum, but Not Cortical Volume Loss, Is Related to Cognitive Dysfunction in Type 1 Diabetic Patients With and Without Microangiopathy
Open the PDF for Ventral Striatum, but Not Cortical Volume Loss, Is Related to Cognitive Dysfunction in Type 1 Diabetic Patients With and Without Microangiopathy in another window
Includes: Supplementary data
Journal Articles

No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years

Dario Iafusco, Silvana Salardi, Giovanni Chiari, Sonia Toni, Ivana Rabbone, Roberta Pesavento, Bruno Pasquino, Antonella de Benedictis, Giulio Maltoni, Carlo Colombo, Lucia Russo, Ornella Massa, Maurizio Sudano, Francesco Cadario, Massimo Porta, Fabrizio Barbetti, the Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)
Journal: Diabetes Care
Diabetes Care 2014;37(8):e181–e182
https://doi.org/10.2337/dc14-0471
Published: 12 July 2014
View article titled, No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years
Open the PDF for No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years in another window
Journal Articles

Proliferative Retinopathy in Type 1 Diabetes Is Associated With Cerebral Microbleeds, Which Is Part of Generalized Microangiopathy

Jorn Woerdeman, Eelco van Duinkerken, Mike P. Wattjes, Frederik Barkhof, Frank J. Snoek, Annette C. Moll, Martin Klein, Michiel P. de Boer, Richard G. IJzerman, Erik H. Serné, Michaela Diamant
Journal: Diabetes Care
Diabetes Care 2014;37(4):1165–1168
https://doi.org/10.2337/dc13-1586
Published: 08 March 2014
View article titled, Proliferative Retinopathy in Type 1 Diabetes Is Associated With Cerebral Microbleeds, Which Is Part of Generalized Microangiopathy
Open the PDF for Proliferative Retinopathy in Type 1 Diabetes Is Associated With Cerebral Microbleeds, Which Is Part of Generalized Microangiopathy in another window
Includes: Supplementary data
Journal Articles

Predicting Development of Proliferative Diabetic Retinopathy

Kristen Harris Nwanyanwu, MD, MBA, Nidhi Talwar, MA, Thomas W. Gardner, MD, MS, James S. Wrobel, DPM, MS, William H. Herman, MD, MPH, Joshua D. Stein, MD, MS
Journal: Diabetes Care
Diabetes Care 2013;36(6):1562–1568
https://doi.org/10.2337/dc12-0790
Published: 15 May 2013
View article titled, Predicting Development of Proliferative Diabetic Retinopathy
Open the PDF for Predicting Development of Proliferative Diabetic Retinopathy in another window
Includes: Supplementary data
Journal Articles

Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors

Jackie Elliott, PHD, Solomon Tesfaye, FRCP, Nish Chaturvedi, MRCP, Rajiv A. Gandhi, MRCP, Lynda K. Stevens, MSC, Celia Emery, PHD, John H. Fuller, FRCP, on behalf of the EURODIAB Prospective Complications Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(10):1896–1900
https://doi.org/10.2337/dc09-0554
Published: 08 July 2009
View article titled, Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors
Open the PDF for Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors in another window
Includes: Supplementary data
Journal Articles

Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes

Caroline K. Kramer, MD, Cristiane B. Leitão, MD, PHD, Luís H. Canani, MD, PHD, Jorge L. Gross, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(12):2233–2237
https://doi.org/10.2337/dc08-1299
Published: 01 December 2008
View article titled, Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes
Open the PDF for Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes in another window
Journal Articles

Proliferative Diabetic Retinopathy in Type 2 Diabetes Is Related to Coronary Artery Calcium in the Veterans Affairs Diabetes Trial (VADT)

Peter D. Reaven, MD, Nicholas Emanuele, MD, Thomas Moritz, PHD, Ronald Klein, MD, Mathew Davis, MD, Kathy Glander, BBA, William Duckworth, MD, Carlos Abraira, MD, for the Veterans Affairs Diabetes Trial (VADT)
Journal: Diabetes Care
Diabetes Care 2008;31(5):952–957
https://doi.org/10.2337/dc07-1926
Published: 01 May 2008
View article titled, Proliferative Diabetic Retinopathy in Type 2 Diabetes Is Related to Coronary Artery Calcium in the Veterans Affairs Diabetes Trial (VADT)
Open the PDF for Proliferative Diabetic Retinopathy in Type 2 Diabetes Is Related to Coronary Artery Calcium in the Veterans Affairs Diabetes Trial (VADT) in another window
Journal Articles

Functional Vascular Endothelial Growth Factor −634G>C SNP Is Associated With Proliferative Diabetic Retinopathy: A case-control study in a Brazilian population of European ancestry

Flavia I.V. Errera, PHD, Luís Henrique Canani, MD, PHD, Maria Elisabeth R. Silva, MD, PHD, Erika Yeh, Walter Takahashi, MD, PHD, Katia G. Santos, PHD, Katia E.P. Souto, PHD, Balduíno Tschiedel, MD, PHD, Israel Roisenberg, MD, PHD, Jorge Luis Gross, MD, PHD, Maria Rita Passos-Bueno, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(2):275–279
https://doi.org/10.2337/dc06-1399
Published: 01 February 2007
View article titled, Functional Vascular Endothelial Growth Factor −634G&gt;C SNP Is Associated With Proliferative Diabetic Retinopathy: <subtitle>A case-control study in a Brazilian population of European ancestry</subtitle>
Open the PDF for Functional Vascular Endothelial Growth Factor −634G>C SNP Is Associated With Proliferative Diabetic Retinopathy: <subtitle>A case-control study in a Brazilian population of European ancestry</subtitle> in another window
Journal Articles

Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women

Auni Juutilainen, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD, Kalevi Pyörälä, MD, Markku Laakso, MD
Journal: Diabetes Care
Diabetes Care 2007;30(2):292–299
https://doi.org/10.2337/dc06-1747
Published: 01 February 2007
View article titled, Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women
Open the PDF for Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women in another window
Journal Articles

Glial Cell Line–Derived Neurotrophic Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy

Nami Nishikiori, MD, Yoshinori Mitamura, MD, Asako Tashimo, MD, Yasushi Nakamura, MD, Takayuki Harada, MD, Makoto Osanai, MD, Norimasa Sawada, MD, Kenji Ohtsuka, MD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2588
https://doi.org/10.2337/diacare.28.10.2588
Published: 01 October 2005
View article titled, Glial Cell Line–Derived Neurotrophic Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy
Open the PDF for Glial Cell Line–Derived Neurotrophic Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy in another window
Journal Articles

Metabolic Control of Diabetes Is Associated With an Improved Response of Diabetic Retinopathy to Panretinal Photocoagulation

Maria G. Kotoula, MD, George N. Koukoulis, MD, Elias Zintzaras, PHD, Constantinos H. Karabatsas, MD, Dimitrios Z. Chatzoulis, MD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2454–2457
https://doi.org/10.2337/diacare.28.10.2454
Published: 01 October 2005
View article titled, Metabolic Control of Diabetes Is Associated With an Improved Response of Diabetic Retinopathy to Panretinal Photocoagulation
Open the PDF for Metabolic Control of Diabetes Is Associated With an Improved Response of Diabetic Retinopathy to Panretinal Photocoagulation in another window
Journal Articles

Erythropoietin Is Highly Elevated in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy

Yoshiya Katsura, MD, Tadashi Okano, MD, Kazuhisa Matsuno, MD, Masahiro Osako, MD, Masahiko Kure, DM, Toshiya Watanabe, MD, Yoshiki Iwaki, MD, Masayuki Noritake, MD, Hiroshi Kosano, PHD, Hideo Nishigori, PHD, Takeshi Matsuoka, MD
Journal: Diabetes Care
Diabetes Care 2005;28(9):2252–2254
https://doi.org/10.2337/diacare.28.9.2252
Published: 01 September 2005
View article titled, Erythropoietin Is Highly Elevated in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy
Open the PDF for Erythropoietin Is Highly Elevated in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy in another window
Journal Articles

Complications of Type 2 Diabetes Among Aboriginal Canadians: Prevalence and associated risk factors

Anthony J.G. Hanley, PHD, Stewart B. Harris, MD, Mary Mamakeesick, RPN, Ken Goodwin, Edith Fiddler, Robert A. Hegele, MD, J. David Spence, MD, Andrew A. House, MD, Ed Brown, MD, Blair Schoales, MD, John R. McLaughlin, PHD, Ronald Klein, MD, Bernard Zinman, MD
Journal: Diabetes Care
Diabetes Care 2005;28(8):2054–2057
https://doi.org/10.2337/diacare.28.8.2054
Published: 01 August 2005
View article titled, Complications of Type 2 Diabetes Among Aboriginal Canadians: <subtitle>Prevalence and associated risk factors</subtitle>
Open the PDF for Complications of Type 2 Diabetes Among Aboriginal Canadians: <subtitle>Prevalence and associated risk factors</subtitle> in another window
Journal Articles

Somatostatin Molecular Variants in the Vitreous Fluid: A comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects

Cristina Hernández, MD, Esther Carrasco, PHD, Roser Casamitjana, MD, Ramon Deulofeu, MD, José García-Arumí, MD, Rafael Simó, MD
Journal: Diabetes Care
Diabetes Care 2005;28(8):1941–1947
https://doi.org/10.2337/diacare.28.8.1941
Published: 01 August 2005
View article titled, Somatostatin Molecular Variants in the Vitreous Fluid: <subtitle>A comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects</subtitle>
Open the PDF for Somatostatin Molecular Variants in the Vitreous Fluid: <subtitle>A comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects</subtitle> in another window